Global Wound Debridement Market
Global Wound Debridement Market

Wound Debridement Comprehensive Study by Type (Gels, Ointments, Surgical devices, Medical gauzes, Ultrasonic devices, Others), Type of Wound (Acute Wound (Incision Wounds, Abrasion Wounds, Others), Chronic Wound (Diabetic Ulcers, Venous Ulcers, Pressure Ulcers, Others), Burns (Radiation Burns, Thermal Burns, Others)), Method (Autolytic, Enzymatic, Mechanical, Surgical, Others), End User (Hospitals, Ambulatory Surgical Centers, Specialized Clinics, Nursing Facilities, Others) Players and Region - Global Market Outlook to 2024

Wound Debridement Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Oct 2019 Edition 220 Pages 210 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Scope of the Study

The rising healthcare expenditure in emerging countries will help to boost the global Wound Debridement market in the forecasted period. Wound debridement refers to the procedure of removal of dead, contaminated, and unhealthy tissue from a wound to promote wound healing. increasing hospitalizations cases, surgeries, and incidences of chronical wounds, the increased investment being made in the sectors, and increasing awareness between patients and their families are ready to spend a higher amount on healthcare. These factors are playing major role in the global Wound Debridement market.

The market study is being classified by Type (Gels, Ointments, Surgical devices, Medical gauzes, Ultrasonic devices and Others) and major geographies with country level break-up.

Advanced Medical Solutions Group plc (United Kingdom), Coloplast A/S (Denmark), ArthroCare Corporation (United States), Misonix, Inc. (United States), Derma Sciences, Inc. (United States), MediWound Ltd (Isreal), PuriCore plc. (United States), Smith & Nephew Plc (United Kingdom) and Lohmann & Rauscher GmbH (Germany) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Medtronic Inc. (Ireland), B. Braun Melsungen (Germany), Convatec Group (United Kingdom), Molnlycke Health Care (Sweden) and Integra Lifesciences (United States).

In order to gain market share and precedence over competitors in the global market are seen growth strategies. Expansion, mergers, acquisition, expansion of product portfolio are some strategies adopted by market key players. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Wound Debridement market throughout the predicted period.

Segment Analysis
AdvanceMarketAnalytics has segmented the market of Global Wound Debridement market by Type, Application and Region.

On the basis of geography, the market of Wound Debridement has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2018. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • The Rise in the Prevalence of Diabetes Escalates Incidence of Chronic Wounds
  • Focus on Autolytic Debridement & Disposable Products

Market Trend
  • The Growing Number of Reimbursement Policy and High in Demand for Better Healthcare
  • The Raising Awareness of Wound Care Treatment and Management

Restraints
  • The Growing Concern Related to Chances of Infection through Contamination

Opportunities
  • Huge Growth Potential for New Entrance
  • High Demand for Emerging Markets

Challenges
  • High Cost Associated with Debridement Products


Market Leaders and their expansionary development strategies
On 31st January 2019, Advanced Medical Solutions Group plc, the surgical and advanced wound care specialist company, has announced it has acquired Sealantis Limited, a developer of an alginate-based tissue adhesive technology platform, for USD 25m in cash with royalties due until December 2027 on sales of any of its products that are currently in development.



Key Target Audience
Wound Debridement Products Manufactures, Distributors and Suppliers, Government Regulatory Bodies, Government Research Organizations, Private Research Organizations and Others

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Gels
  • Ointments
  • Surgical devices
  • Medical gauzes
  • Ultrasonic devices
  • Others
By Type of Wound
  • Acute Wound [Incision Wounds, Abrasion Wounds, Others]
  • Chronic Wound [Diabetic Ulcers, Venous Ulcers, Pressure Ulcers, Others]
  • Burns [Radiation Burns, Thermal Burns, Others]

By Method
  • Autolytic
  • Enzymatic
  • Mechanical
  • Surgical
  • Others

By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Clinics
  • Nursing Facilities
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Rise in the Prevalence of Diabetes Escalates Incidence of Chronic Wounds
      • 3.2.2. Focus on Autolytic Debridement & Disposable Products
    • 3.3. Market Challenges
      • 3.3.1. High Cost Associated with Debridement Products
    • 3.4. Market Trends
      • 3.4.1. The Growing Number of Reimbursement Policy and High in Demand for Better Healthcare
      • 3.4.2. The Raising Awareness of Wound Care Treatment and Management
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Wound Debridement, by Type, Type of Wound, Method, End User and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Wound Debridement (Value)
      • 5.2.1. Global Wound Debridement by: Type (Value)
        • 5.2.1.1. Gels
        • 5.2.1.2. Ointments
        • 5.2.1.3. Surgical devices
        • 5.2.1.4. Medical gauzes
        • 5.2.1.5. Ultrasonic devices
        • 5.2.1.6. Others
      • 5.2.2. Global Wound Debridement by: Type of Wound (Value)
        • 5.2.2.1. Acute Wound [Incision Wounds, Abrasion Wounds, Others]
        • 5.2.2.2. Chronic Wound [Diabetic Ulcers, Venous Ulcers, Pressure Ulcers, Others]
        • 5.2.2.3. Burns [Radiation Burns, Thermal Burns, Others]
      • 5.2.3. Global Wound Debridement by: Method (Value)
        • 5.2.3.1. Autolytic
        • 5.2.3.2. Enzymatic
        • 5.2.3.3. Mechanical
        • 5.2.3.4. Surgical
        • 5.2.3.5. Others
      • 5.2.4. Global Wound Debridement by: End User (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Ambulatory Surgical Centers
        • 5.2.4.3. Specialized Clinics
        • 5.2.4.4. Nursing Facilities
        • 5.2.4.5. Others
      • 5.2.5. Global Wound Debridement Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Wound Debridement: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Advanced Medical Solutions Group plc (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Coloplast A/S (Denmark)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. ArthroCare Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Misonix, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Derma Sciences, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. MediWound Ltd (Isreal)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. PuriCore plc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Smith & Nephew Plc (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Lohmann & Rauscher GmbH (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Wound Debridement Sale, by Type, Type of Wound, Method, End User and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Wound Debridement (Value)
      • 7.2.1. Global Wound Debridement by: Type (Value)
        • 7.2.1.1. Gels
        • 7.2.1.2. Ointments
        • 7.2.1.3. Surgical devices
        • 7.2.1.4. Medical gauzes
        • 7.2.1.5. Ultrasonic devices
        • 7.2.1.6. Others
      • 7.2.2. Global Wound Debridement by: Type of Wound (Value)
        • 7.2.2.1. Acute Wound [Incision Wounds, Abrasion Wounds, Others]
        • 7.2.2.2. Chronic Wound [Diabetic Ulcers, Venous Ulcers, Pressure Ulcers, Others]
        • 7.2.2.3. Burns [Radiation Burns, Thermal Burns, Others]
      • 7.2.3. Global Wound Debridement by: Method (Value)
        • 7.2.3.1. Autolytic
        • 7.2.3.2. Enzymatic
        • 7.2.3.3. Mechanical
        • 7.2.3.4. Surgical
        • 7.2.3.5. Others
      • 7.2.4. Global Wound Debridement by: End User (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Ambulatory Surgical Centers
        • 7.2.4.3. Specialized Clinics
        • 7.2.4.4. Nursing Facilities
        • 7.2.4.5. Others
      • 7.2.5. Global Wound Debridement Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Wound Debridement: by Type(USD Million)
  • Table 2. Wound Debridement Gels , by Region USD Million (2013-2018)
  • Table 3. Wound Debridement Ointments , by Region USD Million (2013-2018)
  • Table 4. Wound Debridement Surgical devices , by Region USD Million (2013-2018)
  • Table 5. Wound Debridement Medical gauzes , by Region USD Million (2013-2018)
  • Table 6. Wound Debridement Ultrasonic devices , by Region USD Million (2013-2018)
  • Table 7. Wound Debridement Others , by Region USD Million (2013-2018)
  • Table 8. Wound Debridement: by Type of Wound(USD Million)
  • Table 9. Wound Debridement Acute Wound [Incision Wounds, Abrasion Wounds, Others] , by Region USD Million (2013-2018)
  • Table 10. Wound Debridement Chronic Wound [Diabetic Ulcers, Venous Ulcers, Pressure Ulcers, Others] , by Region USD Million (2013-2018)
  • Table 11. Wound Debridement Burns [Radiation Burns, Thermal Burns, Others] , by Region USD Million (2013-2018)
  • Table 12. Wound Debridement: by Method(USD Million)
  • Table 13. Wound Debridement Autolytic , by Region USD Million (2013-2018)
  • Table 14. Wound Debridement Enzymatic , by Region USD Million (2013-2018)
  • Table 15. Wound Debridement Mechanical , by Region USD Million (2013-2018)
  • Table 16. Wound Debridement Surgical , by Region USD Million (2013-2018)
  • Table 17. Wound Debridement Others , by Region USD Million (2013-2018)
  • Table 18. Wound Debridement: by End User(USD Million)
  • Table 19. Wound Debridement Hospitals , by Region USD Million (2013-2018)
  • Table 20. Wound Debridement Ambulatory Surgical Centers , by Region USD Million (2013-2018)
  • Table 21. Wound Debridement Specialized Clinics , by Region USD Million (2013-2018)
  • Table 22. Wound Debridement Nursing Facilities , by Region USD Million (2013-2018)
  • Table 23. Wound Debridement Others , by Region USD Million (2013-2018)
  • Table 24. South America Wound Debridement, by Country USD Million (2013-2018)
  • Table 25. South America Wound Debridement, by Type USD Million (2013-2018)
  • Table 26. South America Wound Debridement, by Type of Wound USD Million (2013-2018)
  • Table 27. South America Wound Debridement, by Method USD Million (2013-2018)
  • Table 28. South America Wound Debridement, by End User USD Million (2013-2018)
  • Table 29. Brazil Wound Debridement, by Type USD Million (2013-2018)
  • Table 30. Brazil Wound Debridement, by Type of Wound USD Million (2013-2018)
  • Table 31. Brazil Wound Debridement, by Method USD Million (2013-2018)
  • Table 32. Brazil Wound Debridement, by End User USD Million (2013-2018)
  • Table 33. Argentina Wound Debridement, by Type USD Million (2013-2018)
  • Table 34. Argentina Wound Debridement, by Type of Wound USD Million (2013-2018)
  • Table 35. Argentina Wound Debridement, by Method USD Million (2013-2018)
  • Table 36. Argentina Wound Debridement, by End User USD Million (2013-2018)
  • Table 37. Rest of South America Wound Debridement, by Type USD Million (2013-2018)
  • Table 38. Rest of South America Wound Debridement, by Type of Wound USD Million (2013-2018)
  • Table 39. Rest of South America Wound Debridement, by Method USD Million (2013-2018)
  • Table 40. Rest of South America Wound Debridement, by End User USD Million (2013-2018)
  • Table 41. Asia Pacific Wound Debridement, by Country USD Million (2013-2018)
  • Table 42. Asia Pacific Wound Debridement, by Type USD Million (2013-2018)
  • Table 43. Asia Pacific Wound Debridement, by Type of Wound USD Million (2013-2018)
  • Table 44. Asia Pacific Wound Debridement, by Method USD Million (2013-2018)
  • Table 45. Asia Pacific Wound Debridement, by End User USD Million (2013-2018)
  • Table 46. China Wound Debridement, by Type USD Million (2013-2018)
  • Table 47. China Wound Debridement, by Type of Wound USD Million (2013-2018)
  • Table 48. China Wound Debridement, by Method USD Million (2013-2018)
  • Table 49. China Wound Debridement, by End User USD Million (2013-2018)
  • Table 50. Japan Wound Debridement, by Type USD Million (2013-2018)
  • Table 51. Japan Wound Debridement, by Type of Wound USD Million (2013-2018)
  • Table 52. Japan Wound Debridement, by Method USD Million (2013-2018)
  • Table 53. Japan Wound Debridement, by End User USD Million (2013-2018)
  • Table 54. India Wound Debridement, by Type USD Million (2013-2018)
  • Table 55. India Wound Debridement, by Type of Wound USD Million (2013-2018)
  • Table 56. India Wound Debridement, by Method USD Million (2013-2018)
  • Table 57. India Wound Debridement, by End User USD Million (2013-2018)
  • Table 58. South Korea Wound Debridement, by Type USD Million (2013-2018)
  • Table 59. South Korea Wound Debridement, by Type of Wound USD Million (2013-2018)
  • Table 60. South Korea Wound Debridement, by Method USD Million (2013-2018)
  • Table 61. South Korea Wound Debridement, by End User USD Million (2013-2018)
  • Table 62. Taiwan Wound Debridement, by Type USD Million (2013-2018)
  • Table 63. Taiwan Wound Debridement, by Type of Wound USD Million (2013-2018)
  • Table 64. Taiwan Wound Debridement, by Method USD Million (2013-2018)
  • Table 65. Taiwan Wound Debridement, by End User USD Million (2013-2018)
  • Table 66. Australia Wound Debridement, by Type USD Million (2013-2018)
  • Table 67. Australia Wound Debridement, by Type of Wound USD Million (2013-2018)
  • Table 68. Australia Wound Debridement, by Method USD Million (2013-2018)
  • Table 69. Australia Wound Debridement, by End User USD Million (2013-2018)
  • Table 70. Rest of Asia-Pacific Wound Debridement, by Type USD Million (2013-2018)
  • Table 71. Rest of Asia-Pacific Wound Debridement, by Type of Wound USD Million (2013-2018)
  • Table 72. Rest of Asia-Pacific Wound Debridement, by Method USD Million (2013-2018)
  • Table 73. Rest of Asia-Pacific Wound Debridement, by End User USD Million (2013-2018)
  • Table 74. Europe Wound Debridement, by Country USD Million (2013-2018)
  • Table 75. Europe Wound Debridement, by Type USD Million (2013-2018)
  • Table 76. Europe Wound Debridement, by Type of Wound USD Million (2013-2018)
  • Table 77. Europe Wound Debridement, by Method USD Million (2013-2018)
  • Table 78. Europe Wound Debridement, by End User USD Million (2013-2018)
  • Table 79. Germany Wound Debridement, by Type USD Million (2013-2018)
  • Table 80. Germany Wound Debridement, by Type of Wound USD Million (2013-2018)
  • Table 81. Germany Wound Debridement, by Method USD Million (2013-2018)
  • Table 82. Germany Wound Debridement, by End User USD Million (2013-2018)
  • Table 83. France Wound Debridement, by Type USD Million (2013-2018)
  • Table 84. France Wound Debridement, by Type of Wound USD Million (2013-2018)
  • Table 85. France Wound Debridement, by Method USD Million (2013-2018)
  • Table 86. France Wound Debridement, by End User USD Million (2013-2018)
  • Table 87. Italy Wound Debridement, by Type USD Million (2013-2018)
  • Table 88. Italy Wound Debridement, by Type of Wound USD Million (2013-2018)
  • Table 89. Italy Wound Debridement, by Method USD Million (2013-2018)
  • Table 90. Italy Wound Debridement, by End User USD Million (2013-2018)
  • Table 91. United Kingdom Wound Debridement, by Type USD Million (2013-2018)
  • Table 92. United Kingdom Wound Debridement, by Type of Wound USD Million (2013-2018)
  • Table 93. United Kingdom Wound Debridement, by Method USD Million (2013-2018)
  • Table 94. United Kingdom Wound Debridement, by End User USD Million (2013-2018)
  • Table 95. Netherlands Wound Debridement, by Type USD Million (2013-2018)
  • Table 96. Netherlands Wound Debridement, by Type of Wound USD Million (2013-2018)
  • Table 97. Netherlands Wound Debridement, by Method USD Million (2013-2018)
  • Table 98. Netherlands Wound Debridement, by End User USD Million (2013-2018)
  • Table 99. Rest of Europe Wound Debridement, by Type USD Million (2013-2018)
  • Table 100. Rest of Europe Wound Debridement, by Type of Wound USD Million (2013-2018)
  • Table 101. Rest of Europe Wound Debridement, by Method USD Million (2013-2018)
  • Table 102. Rest of Europe Wound Debridement, by End User USD Million (2013-2018)
  • Table 103. MEA Wound Debridement, by Country USD Million (2013-2018)
  • Table 104. MEA Wound Debridement, by Type USD Million (2013-2018)
  • Table 105. MEA Wound Debridement, by Type of Wound USD Million (2013-2018)
  • Table 106. MEA Wound Debridement, by Method USD Million (2013-2018)
  • Table 107. MEA Wound Debridement, by End User USD Million (2013-2018)
  • Table 108. Middle East Wound Debridement, by Type USD Million (2013-2018)
  • Table 109. Middle East Wound Debridement, by Type of Wound USD Million (2013-2018)
  • Table 110. Middle East Wound Debridement, by Method USD Million (2013-2018)
  • Table 111. Middle East Wound Debridement, by End User USD Million (2013-2018)
  • Table 112. Africa Wound Debridement, by Type USD Million (2013-2018)
  • Table 113. Africa Wound Debridement, by Type of Wound USD Million (2013-2018)
  • Table 114. Africa Wound Debridement, by Method USD Million (2013-2018)
  • Table 115. Africa Wound Debridement, by End User USD Million (2013-2018)
  • Table 116. North America Wound Debridement, by Country USD Million (2013-2018)
  • Table 117. North America Wound Debridement, by Type USD Million (2013-2018)
  • Table 118. North America Wound Debridement, by Type of Wound USD Million (2013-2018)
  • Table 119. North America Wound Debridement, by Method USD Million (2013-2018)
  • Table 120. North America Wound Debridement, by End User USD Million (2013-2018)
  • Table 121. United States Wound Debridement, by Type USD Million (2013-2018)
  • Table 122. United States Wound Debridement, by Type of Wound USD Million (2013-2018)
  • Table 123. United States Wound Debridement, by Method USD Million (2013-2018)
  • Table 124. United States Wound Debridement, by End User USD Million (2013-2018)
  • Table 125. Canada Wound Debridement, by Type USD Million (2013-2018)
  • Table 126. Canada Wound Debridement, by Type of Wound USD Million (2013-2018)
  • Table 127. Canada Wound Debridement, by Method USD Million (2013-2018)
  • Table 128. Canada Wound Debridement, by End User USD Million (2013-2018)
  • Table 129. Mexico Wound Debridement, by Type USD Million (2013-2018)
  • Table 130. Mexico Wound Debridement, by Type of Wound USD Million (2013-2018)
  • Table 131. Mexico Wound Debridement, by Method USD Million (2013-2018)
  • Table 132. Mexico Wound Debridement, by End User USD Million (2013-2018)
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Wound Debridement: by Type(USD Million)
  • Table 143. Wound Debridement Gels , by Region USD Million (2019-2024)
  • Table 144. Wound Debridement Ointments , by Region USD Million (2019-2024)
  • Table 145. Wound Debridement Surgical devices , by Region USD Million (2019-2024)
  • Table 146. Wound Debridement Medical gauzes , by Region USD Million (2019-2024)
  • Table 147. Wound Debridement Ultrasonic devices , by Region USD Million (2019-2024)
  • Table 148. Wound Debridement Others , by Region USD Million (2019-2024)
  • Table 149. Wound Debridement: by Type of Wound(USD Million)
  • Table 150. Wound Debridement Acute Wound [Incision Wounds, Abrasion Wounds, Others] , by Region USD Million (2019-2024)
  • Table 151. Wound Debridement Chronic Wound [Diabetic Ulcers, Venous Ulcers, Pressure Ulcers, Others] , by Region USD Million (2019-2024)
  • Table 152. Wound Debridement Burns [Radiation Burns, Thermal Burns, Others] , by Region USD Million (2019-2024)
  • Table 153. Wound Debridement: by Method(USD Million)
  • Table 154. Wound Debridement Autolytic , by Region USD Million (2019-2024)
  • Table 155. Wound Debridement Enzymatic , by Region USD Million (2019-2024)
  • Table 156. Wound Debridement Mechanical , by Region USD Million (2019-2024)
  • Table 157. Wound Debridement Surgical , by Region USD Million (2019-2024)
  • Table 158. Wound Debridement Others , by Region USD Million (2019-2024)
  • Table 159. Wound Debridement: by End User(USD Million)
  • Table 160. Wound Debridement Hospitals , by Region USD Million (2019-2024)
  • Table 161. Wound Debridement Ambulatory Surgical Centers , by Region USD Million (2019-2024)
  • Table 162. Wound Debridement Specialized Clinics , by Region USD Million (2019-2024)
  • Table 163. Wound Debridement Nursing Facilities , by Region USD Million (2019-2024)
  • Table 164. Wound Debridement Others , by Region USD Million (2019-2024)
  • Table 165. South America Wound Debridement, by Country USD Million (2019-2024)
  • Table 166. South America Wound Debridement, by Type USD Million (2019-2024)
  • Table 167. South America Wound Debridement, by Type of Wound USD Million (2019-2024)
  • Table 168. South America Wound Debridement, by Method USD Million (2019-2024)
  • Table 169. South America Wound Debridement, by End User USD Million (2019-2024)
  • Table 170. Brazil Wound Debridement, by Type USD Million (2019-2024)
  • Table 171. Brazil Wound Debridement, by Type of Wound USD Million (2019-2024)
  • Table 172. Brazil Wound Debridement, by Method USD Million (2019-2024)
  • Table 173. Brazil Wound Debridement, by End User USD Million (2019-2024)
  • Table 174. Argentina Wound Debridement, by Type USD Million (2019-2024)
  • Table 175. Argentina Wound Debridement, by Type of Wound USD Million (2019-2024)
  • Table 176. Argentina Wound Debridement, by Method USD Million (2019-2024)
  • Table 177. Argentina Wound Debridement, by End User USD Million (2019-2024)
  • Table 178. Rest of South America Wound Debridement, by Type USD Million (2019-2024)
  • Table 179. Rest of South America Wound Debridement, by Type of Wound USD Million (2019-2024)
  • Table 180. Rest of South America Wound Debridement, by Method USD Million (2019-2024)
  • Table 181. Rest of South America Wound Debridement, by End User USD Million (2019-2024)
  • Table 182. Asia Pacific Wound Debridement, by Country USD Million (2019-2024)
  • Table 183. Asia Pacific Wound Debridement, by Type USD Million (2019-2024)
  • Table 184. Asia Pacific Wound Debridement, by Type of Wound USD Million (2019-2024)
  • Table 185. Asia Pacific Wound Debridement, by Method USD Million (2019-2024)
  • Table 186. Asia Pacific Wound Debridement, by End User USD Million (2019-2024)
  • Table 187. China Wound Debridement, by Type USD Million (2019-2024)
  • Table 188. China Wound Debridement, by Type of Wound USD Million (2019-2024)
  • Table 189. China Wound Debridement, by Method USD Million (2019-2024)
  • Table 190. China Wound Debridement, by End User USD Million (2019-2024)
  • Table 191. Japan Wound Debridement, by Type USD Million (2019-2024)
  • Table 192. Japan Wound Debridement, by Type of Wound USD Million (2019-2024)
  • Table 193. Japan Wound Debridement, by Method USD Million (2019-2024)
  • Table 194. Japan Wound Debridement, by End User USD Million (2019-2024)
  • Table 195. India Wound Debridement, by Type USD Million (2019-2024)
  • Table 196. India Wound Debridement, by Type of Wound USD Million (2019-2024)
  • Table 197. India Wound Debridement, by Method USD Million (2019-2024)
  • Table 198. India Wound Debridement, by End User USD Million (2019-2024)
  • Table 199. South Korea Wound Debridement, by Type USD Million (2019-2024)
  • Table 200. South Korea Wound Debridement, by Type of Wound USD Million (2019-2024)
  • Table 201. South Korea Wound Debridement, by Method USD Million (2019-2024)
  • Table 202. South Korea Wound Debridement, by End User USD Million (2019-2024)
  • Table 203. Taiwan Wound Debridement, by Type USD Million (2019-2024)
  • Table 204. Taiwan Wound Debridement, by Type of Wound USD Million (2019-2024)
  • Table 205. Taiwan Wound Debridement, by Method USD Million (2019-2024)
  • Table 206. Taiwan Wound Debridement, by End User USD Million (2019-2024)
  • Table 207. Australia Wound Debridement, by Type USD Million (2019-2024)
  • Table 208. Australia Wound Debridement, by Type of Wound USD Million (2019-2024)
  • Table 209. Australia Wound Debridement, by Method USD Million (2019-2024)
  • Table 210. Australia Wound Debridement, by End User USD Million (2019-2024)
  • Table 211. Rest of Asia-Pacific Wound Debridement, by Type USD Million (2019-2024)
  • Table 212. Rest of Asia-Pacific Wound Debridement, by Type of Wound USD Million (2019-2024)
  • Table 213. Rest of Asia-Pacific Wound Debridement, by Method USD Million (2019-2024)
  • Table 214. Rest of Asia-Pacific Wound Debridement, by End User USD Million (2019-2024)
  • Table 215. Europe Wound Debridement, by Country USD Million (2019-2024)
  • Table 216. Europe Wound Debridement, by Type USD Million (2019-2024)
  • Table 217. Europe Wound Debridement, by Type of Wound USD Million (2019-2024)
  • Table 218. Europe Wound Debridement, by Method USD Million (2019-2024)
  • Table 219. Europe Wound Debridement, by End User USD Million (2019-2024)
  • Table 220. Germany Wound Debridement, by Type USD Million (2019-2024)
  • Table 221. Germany Wound Debridement, by Type of Wound USD Million (2019-2024)
  • Table 222. Germany Wound Debridement, by Method USD Million (2019-2024)
  • Table 223. Germany Wound Debridement, by End User USD Million (2019-2024)
  • Table 224. France Wound Debridement, by Type USD Million (2019-2024)
  • Table 225. France Wound Debridement, by Type of Wound USD Million (2019-2024)
  • Table 226. France Wound Debridement, by Method USD Million (2019-2024)
  • Table 227. France Wound Debridement, by End User USD Million (2019-2024)
  • Table 228. Italy Wound Debridement, by Type USD Million (2019-2024)
  • Table 229. Italy Wound Debridement, by Type of Wound USD Million (2019-2024)
  • Table 230. Italy Wound Debridement, by Method USD Million (2019-2024)
  • Table 231. Italy Wound Debridement, by End User USD Million (2019-2024)
  • Table 232. United Kingdom Wound Debridement, by Type USD Million (2019-2024)
  • Table 233. United Kingdom Wound Debridement, by Type of Wound USD Million (2019-2024)
  • Table 234. United Kingdom Wound Debridement, by Method USD Million (2019-2024)
  • Table 235. United Kingdom Wound Debridement, by End User USD Million (2019-2024)
  • Table 236. Netherlands Wound Debridement, by Type USD Million (2019-2024)
  • Table 237. Netherlands Wound Debridement, by Type of Wound USD Million (2019-2024)
  • Table 238. Netherlands Wound Debridement, by Method USD Million (2019-2024)
  • Table 239. Netherlands Wound Debridement, by End User USD Million (2019-2024)
  • Table 240. Rest of Europe Wound Debridement, by Type USD Million (2019-2024)
  • Table 241. Rest of Europe Wound Debridement, by Type of Wound USD Million (2019-2024)
  • Table 242. Rest of Europe Wound Debridement, by Method USD Million (2019-2024)
  • Table 243. Rest of Europe Wound Debridement, by End User USD Million (2019-2024)
  • Table 244. MEA Wound Debridement, by Country USD Million (2019-2024)
  • Table 245. MEA Wound Debridement, by Type USD Million (2019-2024)
  • Table 246. MEA Wound Debridement, by Type of Wound USD Million (2019-2024)
  • Table 247. MEA Wound Debridement, by Method USD Million (2019-2024)
  • Table 248. MEA Wound Debridement, by End User USD Million (2019-2024)
  • Table 249. Middle East Wound Debridement, by Type USD Million (2019-2024)
  • Table 250. Middle East Wound Debridement, by Type of Wound USD Million (2019-2024)
  • Table 251. Middle East Wound Debridement, by Method USD Million (2019-2024)
  • Table 252. Middle East Wound Debridement, by End User USD Million (2019-2024)
  • Table 253. Africa Wound Debridement, by Type USD Million (2019-2024)
  • Table 254. Africa Wound Debridement, by Type of Wound USD Million (2019-2024)
  • Table 255. Africa Wound Debridement, by Method USD Million (2019-2024)
  • Table 256. Africa Wound Debridement, by End User USD Million (2019-2024)
  • Table 257. North America Wound Debridement, by Country USD Million (2019-2024)
  • Table 258. North America Wound Debridement, by Type USD Million (2019-2024)
  • Table 259. North America Wound Debridement, by Type of Wound USD Million (2019-2024)
  • Table 260. North America Wound Debridement, by Method USD Million (2019-2024)
  • Table 261. North America Wound Debridement, by End User USD Million (2019-2024)
  • Table 262. United States Wound Debridement, by Type USD Million (2019-2024)
  • Table 263. United States Wound Debridement, by Type of Wound USD Million (2019-2024)
  • Table 264. United States Wound Debridement, by Method USD Million (2019-2024)
  • Table 265. United States Wound Debridement, by End User USD Million (2019-2024)
  • Table 266. Canada Wound Debridement, by Type USD Million (2019-2024)
  • Table 267. Canada Wound Debridement, by Type of Wound USD Million (2019-2024)
  • Table 268. Canada Wound Debridement, by Method USD Million (2019-2024)
  • Table 269. Canada Wound Debridement, by End User USD Million (2019-2024)
  • Table 270. Mexico Wound Debridement, by Type USD Million (2019-2024)
  • Table 271. Mexico Wound Debridement, by Type of Wound USD Million (2019-2024)
  • Table 272. Mexico Wound Debridement, by Method USD Million (2019-2024)
  • Table 273. Mexico Wound Debridement, by End User USD Million (2019-2024)
  • Table 274. Research Programs/Design for This Report
  • Table 275. Key Data Information from Secondary Sources
  • Table 276. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Wound Debridement: by Type USD Million (2013-2018)
  • Figure 5. Global Wound Debridement: by Type of Wound USD Million (2013-2018)
  • Figure 6. Global Wound Debridement: by Method USD Million (2013-2018)
  • Figure 7. Global Wound Debridement: by End User USD Million (2013-2018)
  • Figure 8. South America Wound Debridement Share (%), by Country
  • Figure 9. Asia Pacific Wound Debridement Share (%), by Country
  • Figure 10. Europe Wound Debridement Share (%), by Country
  • Figure 11. MEA Wound Debridement Share (%), by Country
  • Figure 12. North America Wound Debridement Share (%), by Country
  • Figure 13. Global Wound Debridement share by Players 2018 (%)
  • Figure 14. Global Wound Debridement share by Players (Top 3) 2018(%)
  • Figure 15. Global Wound Debridement share by Players (Top 5) 2018(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Advanced Medical Solutions Group plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 18. Advanced Medical Solutions Group plc (United Kingdom) Revenue: by Geography 2018
  • Figure 19. Coloplast A/S (Denmark) Revenue, Net Income and Gross profit
  • Figure 20. Coloplast A/S (Denmark) Revenue: by Geography 2018
  • Figure 21. ArthroCare Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 22. ArthroCare Corporation (United States) Revenue: by Geography 2018
  • Figure 23. Misonix, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Misonix, Inc. (United States) Revenue: by Geography 2018
  • Figure 25. Derma Sciences, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Derma Sciences, Inc. (United States) Revenue: by Geography 2018
  • Figure 27. MediWound Ltd (Isreal) Revenue, Net Income and Gross profit
  • Figure 28. MediWound Ltd (Isreal) Revenue: by Geography 2018
  • Figure 29. PuriCore plc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. PuriCore plc. (United States) Revenue: by Geography 2018
  • Figure 31. Smith & Nephew Plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. Smith & Nephew Plc (United Kingdom) Revenue: by Geography 2018
  • Figure 33. Lohmann & Rauscher GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 34. Lohmann & Rauscher GmbH (Germany) Revenue: by Geography 2018
  • Figure 35. Global Wound Debridement: by Type USD Million (2019-2024)
  • Figure 36. Global Wound Debridement: by Type of Wound USD Million (2019-2024)
  • Figure 37. Global Wound Debridement: by Method USD Million (2019-2024)
  • Figure 38. Global Wound Debridement: by End User USD Million (2019-2024)
  • Figure 39. South America Wound Debridement Share (%), by Country
  • Figure 40. Asia Pacific Wound Debridement Share (%), by Country
  • Figure 41. Europe Wound Debridement Share (%), by Country
  • Figure 42. MEA Wound Debridement Share (%), by Country
  • Figure 43. North America Wound Debridement Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Advanced Medical Solutions Group plc (United Kingdom)
  • Coloplast A/S (Denmark)
  • ArthroCare Corporation (United States)
  • Misonix, Inc. (United States)
  • Derma Sciences, Inc. (United States)
  • MediWound Ltd (Isreal)
  • PuriCore plc. (United States)
  • Smith & Nephew Plc (United Kingdom)
  • Lohmann & Rauscher GmbH (Germany)
Additional players considered in the study are as follows:
Medtronic Inc. (Ireland) , B. Braun Melsungen (Germany) , Convatec Group (United Kingdom) , Molnlycke Health Care (Sweden) , Integra Lifesciences (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation